COVID-19 papers in Hybrid journals:
All manuscripts describing COVID-19 or coronavirus-related research published in Hybrid journals will be free to access for one month after publication.
You can view a full list of Hybrid journals here. Please check with the journal’s editorial office directly about their COVID-19 article policy, or email OpenResearch@cambridge.org.
Authors should share important information with public health authorities. We encourage all authors to share all data about the 2019-nCoV outbreak in confidence with the World Health Organization. The WHO is asking that going forward submissions/pre-prints be sent to covid19preprint@who.int. Authors are encouraged to post submitted relevant manuscripts under review to bioRxiv, medRxiv, Cambridge Open Engage, or other relevant pre-print servers.
The Press plays a global role in education and research and shares the University’s mission to contribute to society through our work. Sharing research can play an important role in tackling shared threats. As such, we have created a special collection of free to read articles and book chapters related to the coronavirus that will be continually updated as new research becomes available www.cambridge.org/coronavirus
C19 Rapid Review Initiative:
We are pleased to confirm we have joined the C19RapidReview initiative, working with other publishers to ensure vital COVID-19 research is reviewed and published as quickly as possible; three of our journals, Experimental Results, Epidemiology & Infection and Data & Policy are taking part. The aim of the initiative is to ensure there is a sufficient pool of reviewers available to focus on reviewing the high volume of COVID-19 research and to help facilitate the need for rapid publication. If you have suitable expertise in this field and would like to add your name to the list of available reviewers for these journals, please sign up here.